Bortezomib retreatment for relapsed and refractory multiple myeloma in real‐world clinical practice

AIMS: Studies have shown that bortezomib retreatment is effective in relapsed/refractory multiple myeloma (MM). The observational, prospective electronic VELCADE(®) OBservational Study (eVOBS) study assessed bortezomib‐based therapies for patients with MM in everyday practice. Here, we report on tho...

Descripción completa

Detalles Bibliográficos
Autores principales: Hulin, Cyrille, de la Rubia, Javier, Dimopoulos, Meletios A., Terpos, Evangelos, Katodritou, Eirini, Hungria, Vania, De Samblanx, Hadewijch, Stoppa, Anne‐Marie, Aagesen, Jesper, Sargin, Deniz, Sioni, Anastasia, Belch, Andrew, Diels, Joris, Olie, Robert A., Robinson, Don, Potamianou, Anna, van de Velde, Helgi, Delforge, Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346989/
https://www.ncbi.nlm.nih.gov/pubmed/30697597
http://dx.doi.org/10.1002/hsr2.104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346989/
https://www.ncbi.nlm.nih.gov/pubmed/30697597
http://dx.doi.org/10.1002/hsr2.104

Ejemplares similares